XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Stock-Based Compensation  
Schedule of stock-based compensation expense attributable to share-based payments made to employees and directors and included in operating expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

    

June 30, 

​

June 30, 

(in thousands)

​

2022

    

2021

​

2022

    

2021

Stock-based compensation:

​

​

​

    

​

​

​

​

​

    

​

​

Research and development

​

​

​

​

​

​

​

​

​

​

​

​

Employee Stock Purchase Plan

​

$

9

    

$

3

​

$

15

    

$

15

Equity Incentive Plan

​

​

52

    

​

50

​

​

141

    

​

418

​

​

$

61

    

$

53

​

$

156

    

$

433

General and administrative

​

 

​

​

​

​

​

 

​

​

​

​

Employee Stock Purchase Plan

​

$

1

    

$

1

​

$

3

    

$

3

Equity Incentive Plan

​

​

500

    

​

350

​

​

948

    

​

1,079

​

​

$

501

    

$

351

​

$

951

    

$

1,082

Total stock-based compensation expense

​

$

562

    

$

404

​

$

1,107

    

$

1,515

Schedule of weighted average assumptions applied to options

​

​

​

​

​

​

​

​

​

​

    

2022

    

2021

 

Average risk-free interest rate

 

​

2.3%

​

​

0.4%

​

Expected dividend yield

​

 

​

—

​

​

—

​

Expected lives (years)

 

​

4.0

​

​

3.6

​

Expected volatility

 

​

102%

​

​

87%

​

Weighted average exercise price (per share)

​

$

0.53

​

$

3.66

​

Schedule of information related to outstanding and exercisable options

​

​

​

​

​

​

​

​

​

​

​

​

​

($ in thousands, except per share data)

​

Stock
Options

​

Weighted-Average
Exercise Price

​

Weighted-Average
Remaining
Contractual Life
(in years)

​

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2021

 

5,202,006

​

$

8.06

 

5.9

​

$

2,949

​

Granted

 

660,700

​

​

0.53

​

​

​

​

​

​

Exercised

 

—

​

​

—

​

​

​

​

​

​

Forfeited

 

—

​

​

—

​

​

​

​

​

​

Expired

 

(588,038)

​

​

2.87

​

​

​

​

​

​

Outstanding at June 30, 2022 (1)

 

5,274,668

​

$

7.70

​

6.6

​

$

—

​

Exercisable at June 30, 2022

 

3,818,724

​

$

10.16

​

5.6

​

$

—

​

(1)Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.
Schedule of information related to restricted stock activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Time-based Awards

 

​

Market/Performance-based Awards

($ in thousands, except per share data)

​

Number of Shares

​

Weighted-Average

Grant Date

Fair Value

 

​

Number of Shares

​

Weighted-Average

Grant Date

Fair Value

Nonvested shares at December 31, 2021

 

68,675

​

$

2.30

​

 

507,028

​

$

1.54

Granted

 

—

​

 

—

​

 

—

​

 

—

Cancelled

 

—

​

 

—

​

 

—

​

 

—

Vested

 

(27,212)

​

 

2.43

​

 

—

​

 

—

Nonvested shares at June 30, 2022

 

41,463

​

$

2.21

​

 

507,028

​

$

1.54